Defensin-I, an antimicrobial peptide present in the saliva of patients with oral diseases

Nobuyoshi Mizukawa, K. Sugiyama, T. Ueno, K. Mishima, S. Takagi, T. Sugahara

Research output: Contribution to journalArticle

58 Citations (Scopus)

Abstract

OBJECTIVES AND DESIGN: A preceding paper has noted a detection of defensin-I (HNP-I), a peptide with antimicrobial and cytotoxic properties, in the saliva of patients with oral squamous cell carcinoma. The present study deals with the presence of HNP-I in the saliva of patients with various oral diseases. METHODS: Whole saliva samples were obtained from the patients. HNP- I in the saliva was isolated and purified by HPLC and the amino acid sequence of the peptide was determined. The molecular weight of HNP-I was measured by mass spectrometry. The concentration of HNP-I in saliva was determined by comparing the height of eluted HNP-I with that of a synthetic HNP-I standard. RESULTS: The concentrations of HNP-I in the saliva of patients with oral lichen planus (n = 5), leukoplakia (n = 4), and glossitis associated with iron deficiency (n = 4) were 8.3 ± 4.3 μg ml-1, 13.2 ± 7.9 μg ml-1, and 11.4 ± 4.9 μg ml-1, (mean ± s.d.), respectively. These concentrations were significantly higher than those in healthy subjects (0.8 μg ml-1) (P <0.01). In contrast, salivary HNP-I concentrations in patients with glossodynia (n = 4) and oral discomfort (n = 4) were similar to those in healthy subjects. CONCLUSIONS: Since HNP-I is a non-specific defensive peptide present in neutrophils, it may play an important role in the protection against diseases such as oral lichen planus, leukoplakia, and glossitis associated with iron deficiency.

Original languageEnglish
Pages (from-to)139-142
Number of pages4
JournalOral Diseases
Volume5
Issue number2
Publication statusPublished - Apr 1999

Fingerprint

Mouth Diseases
Defensins
Saliva
Peptides
Glossitis
Oral Lichen Planus
Leukoplakia
Glossalgia
Healthy Volunteers
Iron
Amino Acid Sequence
Squamous Cell Carcinoma
Mass Spectrometry
Neutrophils
Molecular Weight
High Pressure Liquid Chromatography

Keywords

  • Defensin
  • HNP-I
  • Oral disease
  • Reversed-phase HPLC
  • Saliva

ASJC Scopus subject areas

  • Dentistry(all)

Cite this

Mizukawa, N., Sugiyama, K., Ueno, T., Mishima, K., Takagi, S., & Sugahara, T. (1999). Defensin-I, an antimicrobial peptide present in the saliva of patients with oral diseases. Oral Diseases, 5(2), 139-142.

Defensin-I, an antimicrobial peptide present in the saliva of patients with oral diseases. / Mizukawa, Nobuyoshi; Sugiyama, K.; Ueno, T.; Mishima, K.; Takagi, S.; Sugahara, T.

In: Oral Diseases, Vol. 5, No. 2, 04.1999, p. 139-142.

Research output: Contribution to journalArticle

Mizukawa, N, Sugiyama, K, Ueno, T, Mishima, K, Takagi, S & Sugahara, T 1999, 'Defensin-I, an antimicrobial peptide present in the saliva of patients with oral diseases', Oral Diseases, vol. 5, no. 2, pp. 139-142.
Mizukawa N, Sugiyama K, Ueno T, Mishima K, Takagi S, Sugahara T. Defensin-I, an antimicrobial peptide present in the saliva of patients with oral diseases. Oral Diseases. 1999 Apr;5(2):139-142.
Mizukawa, Nobuyoshi ; Sugiyama, K. ; Ueno, T. ; Mishima, K. ; Takagi, S. ; Sugahara, T. / Defensin-I, an antimicrobial peptide present in the saliva of patients with oral diseases. In: Oral Diseases. 1999 ; Vol. 5, No. 2. pp. 139-142.
@article{17cd1e32b48e4d3abf6e340713b47990,
title = "Defensin-I, an antimicrobial peptide present in the saliva of patients with oral diseases",
abstract = "OBJECTIVES AND DESIGN: A preceding paper has noted a detection of defensin-I (HNP-I), a peptide with antimicrobial and cytotoxic properties, in the saliva of patients with oral squamous cell carcinoma. The present study deals with the presence of HNP-I in the saliva of patients with various oral diseases. METHODS: Whole saliva samples were obtained from the patients. HNP- I in the saliva was isolated and purified by HPLC and the amino acid sequence of the peptide was determined. The molecular weight of HNP-I was measured by mass spectrometry. The concentration of HNP-I in saliva was determined by comparing the height of eluted HNP-I with that of a synthetic HNP-I standard. RESULTS: The concentrations of HNP-I in the saliva of patients with oral lichen planus (n = 5), leukoplakia (n = 4), and glossitis associated with iron deficiency (n = 4) were 8.3 ± 4.3 μg ml-1, 13.2 ± 7.9 μg ml-1, and 11.4 ± 4.9 μg ml-1, (mean ± s.d.), respectively. These concentrations were significantly higher than those in healthy subjects (0.8 μg ml-1) (P <0.01). In contrast, salivary HNP-I concentrations in patients with glossodynia (n = 4) and oral discomfort (n = 4) were similar to those in healthy subjects. CONCLUSIONS: Since HNP-I is a non-specific defensive peptide present in neutrophils, it may play an important role in the protection against diseases such as oral lichen planus, leukoplakia, and glossitis associated with iron deficiency.",
keywords = "Defensin, HNP-I, Oral disease, Reversed-phase HPLC, Saliva",
author = "Nobuyoshi Mizukawa and K. Sugiyama and T. Ueno and K. Mishima and S. Takagi and T. Sugahara",
year = "1999",
month = "4",
language = "English",
volume = "5",
pages = "139--142",
journal = "Oral Diseases",
issn = "1354-523X",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Defensin-I, an antimicrobial peptide present in the saliva of patients with oral diseases

AU - Mizukawa, Nobuyoshi

AU - Sugiyama, K.

AU - Ueno, T.

AU - Mishima, K.

AU - Takagi, S.

AU - Sugahara, T.

PY - 1999/4

Y1 - 1999/4

N2 - OBJECTIVES AND DESIGN: A preceding paper has noted a detection of defensin-I (HNP-I), a peptide with antimicrobial and cytotoxic properties, in the saliva of patients with oral squamous cell carcinoma. The present study deals with the presence of HNP-I in the saliva of patients with various oral diseases. METHODS: Whole saliva samples were obtained from the patients. HNP- I in the saliva was isolated and purified by HPLC and the amino acid sequence of the peptide was determined. The molecular weight of HNP-I was measured by mass spectrometry. The concentration of HNP-I in saliva was determined by comparing the height of eluted HNP-I with that of a synthetic HNP-I standard. RESULTS: The concentrations of HNP-I in the saliva of patients with oral lichen planus (n = 5), leukoplakia (n = 4), and glossitis associated with iron deficiency (n = 4) were 8.3 ± 4.3 μg ml-1, 13.2 ± 7.9 μg ml-1, and 11.4 ± 4.9 μg ml-1, (mean ± s.d.), respectively. These concentrations were significantly higher than those in healthy subjects (0.8 μg ml-1) (P <0.01). In contrast, salivary HNP-I concentrations in patients with glossodynia (n = 4) and oral discomfort (n = 4) were similar to those in healthy subjects. CONCLUSIONS: Since HNP-I is a non-specific defensive peptide present in neutrophils, it may play an important role in the protection against diseases such as oral lichen planus, leukoplakia, and glossitis associated with iron deficiency.

AB - OBJECTIVES AND DESIGN: A preceding paper has noted a detection of defensin-I (HNP-I), a peptide with antimicrobial and cytotoxic properties, in the saliva of patients with oral squamous cell carcinoma. The present study deals with the presence of HNP-I in the saliva of patients with various oral diseases. METHODS: Whole saliva samples were obtained from the patients. HNP- I in the saliva was isolated and purified by HPLC and the amino acid sequence of the peptide was determined. The molecular weight of HNP-I was measured by mass spectrometry. The concentration of HNP-I in saliva was determined by comparing the height of eluted HNP-I with that of a synthetic HNP-I standard. RESULTS: The concentrations of HNP-I in the saliva of patients with oral lichen planus (n = 5), leukoplakia (n = 4), and glossitis associated with iron deficiency (n = 4) were 8.3 ± 4.3 μg ml-1, 13.2 ± 7.9 μg ml-1, and 11.4 ± 4.9 μg ml-1, (mean ± s.d.), respectively. These concentrations were significantly higher than those in healthy subjects (0.8 μg ml-1) (P <0.01). In contrast, salivary HNP-I concentrations in patients with glossodynia (n = 4) and oral discomfort (n = 4) were similar to those in healthy subjects. CONCLUSIONS: Since HNP-I is a non-specific defensive peptide present in neutrophils, it may play an important role in the protection against diseases such as oral lichen planus, leukoplakia, and glossitis associated with iron deficiency.

KW - Defensin

KW - HNP-I

KW - Oral disease

KW - Reversed-phase HPLC

KW - Saliva

UR - http://www.scopus.com/inward/record.url?scp=0032589454&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032589454&partnerID=8YFLogxK

M3 - Article

VL - 5

SP - 139

EP - 142

JO - Oral Diseases

JF - Oral Diseases

SN - 1354-523X

IS - 2

ER -